EGI
DCPH

EAM Global Investors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

EAM Global Investors’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-81,322
Closed -$1.5M – 249
2022
Q3 		$1.5M Buy
+81,322
New +$1.28M 0.4% 134
2020
Q1 		– Sell
-41,530
Closed -$2.58M – 140
2019
Q4 		$2.58M Buy
+41,530
New +$1.97M 1.03% 22
2018
Q4 		– Sell
-28,089
Closed -$1.09M – 171
2018
Q3 		$1.09M Hold
28,089
– – 0.44% 125
2018
Q2 		$1.1M Buy
+28,089
New +$827K 0.54% 113

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

EAM Global Investors's DCPH Position: Q4 2022 in Review

EAM Global Investors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2022, closing a stake of 81,322 shares — an estimated $1.5M sold.

EAM Global Investors first reported a position in DCPH in Q2 2018 and held it in 4 quarters. The position peaked at $2.58M in Q4 2019. 143 funds tracked by Wall St. Rank hold DCPH as of Q4 2022.

  • EAM Global Investors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • EAM Global Investors sold 81,322 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $1.5M.
  • EAM Global Investors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 4 quarters.
  • EAM Global Investors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.58M in Q4 2019.
  • 143 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on EAM Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.